Literature DB >> 24677329

Summary of proceedings of the second World Congress on Thyroid Cancer.

Lukasz Czerwonka1, Jeremy Freeman, Bryan McIver, Gregory W Randolph, Jatin P Shah, Ashok R Shaha, Steven I Sherman, R Michael Tuttle, Ian J Witterick.   

Abstract

The second World Congress on Thyroid Cancer was held from July 10 to July 14, 2013, in Toronto, Canada. Its purpose was to provide a platform for the multidisciplinary discussion on research, education, and patient management of thyroid malignancy. Herein, we summarize the latest major trends and controversies within the field of thyroid oncology as discussed in the Congress including the use of ultrasound, standardization of cytology, role of molecular testing, treatment options for small recurrence including ablation and observation, management of recurrent laryngeal nerve injury, importance of identification of the external branch of the superior laryngeal nerve, role of minimally invasive thyroid surgery, trends in radioactive iodine treatment, advancements in targeted agents, and the importance of personalizing treatment to individual patients.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  molecular testing; observation; personalized medicine; thyroid cancer; ultrasound

Mesh:

Substances:

Year:  2014        PMID: 24677329     DOI: 10.1002/hed.23631

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  Thyroid Surgery: Whose Domain Is It?

Authors:  Peter Zbären; Jatin P Shah; Gregory W Randolph; Carl E Silver; Kerry D Olsen; Ashok R Shaha; Mark Zafereo; Luiz P Kowalski; Carlos Suarez; Alvaro Sanabria; Vincent Vander Poorten; Iain Nixon; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2019-08-10       Impact factor: 3.845

Review 2.  Targeted Radionuclide Therapy: Practical Applications and Future Prospects.

Authors:  Katherine Zukotynski; Hossein Jadvar; Jacek Capala; Frederic Fahey
Journal:  Biomark Cancer       Date:  2016-05-18

Review 3.  Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors.

Authors:  Yanhong Luo; Hua Zhu; Tao Tan; Jianfeng He
Journal:  Front Pharmacol       Date:  2018-09-10       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.